Nutritional assessment for predicting clinical evolution in gastro-enteropancreatic neuroendocrine tumors

被引：0
|
作者：
Alzas-Teomiro, C. M. [1 ]
Leon-Idougourram, S. [2 ]
Alcantara-Laguna, M. [2 ]
Molina-Puertas, M. J. [2 ]
Galvez-Moreno, M. A. [2 ]
Herrera-Martinez, A. D. [2 ]
机构：
[1] Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba, Cordoba, Spain
[2] Reina Sofia Univ Hosp, Cordoba, Spain
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2021年 / 33卷
关键词：
neuroendocrine; gep; nutrition;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
D02
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [21] The clinicopathological characteristics of gastro enteropancreatic neuroendocrine tumors - A single center experience from Pakistan
    Ali, Y.
    Rahat, A.
    Sajad, M.
    Ikram, S.
    Shah, M. H.
    Malik, I
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 43 - 43
  • [22] Intestinal obstruction (IO) in patients receiving peptide receptor radionuclide therapy (PRRT) for gastro-enteropancreatic neuroendocrine tumors (GEP-NETs): Potential predictors and association with overall survival (OS)
    Badawy, M.
    Hobday, T.
    Johnson, G.
    Halfdanarson, T.
    Young, J.
    Packard, A.
    Thorpe, M.
    Jain, M.
    Eiring, R.
    Patton, C.
    Gansen, D.
    Kendi, A.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 173 - 173
  • [23] Osseous metastases of gastro-enteropancreatic neuroendocrine tumours Diagnostic value of intra-therapeutic 177Lu-octreotate imaging in comparison with bone scintigraphy
    Sabet, A.
    Ezziddin, S.
    Heinemann, F.
    Guhlke, S.
    Muckle, M.
    Willinek, W.
    Biersack, H. -J.
    Ahmadzadehfar, H.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2012, 51 (03): : 95 - 100
  • [24] Molecular Targeted Therapy in Enteropancreatic Neuroendocrine Tumors: From Biology to Clinical Practice
    Fazio, N.
    Scarpa, A.
    Falconi, M.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (08) : 1017 - 1025
  • [25] Upfront Oxaliplatin-Fluoropyrimidine chemotherapy and Somatostatin Analogues (SSA) in advanced well-differentiated G2/G3 gastro-enteropancreatic neuroendocrine tumors (GEP-NETs)
    Maratta, M. G.
    Sparagna, I
    d'Agostino, F.
    Occhipinti, D.
    Raia, S.
    Chiloiro, S.
    Bianchi, A.
    Rindi, G.
    Tortora, G.
    Schinzari, G.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 244 - 244
  • [26] Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications
    Merola, Elettra
    Pavel, Marianne E.
    Panzuto, Francesco
    Capurso, Gabriele
    Cicchese, Noemi
    Rinke, Anja
    Gress, Thomas M.
    Iannicelli, Elsa
    Prosperi, Daniela
    Pizzichini, Patrizia
    Prasad, Vikas
    Kump, Patrizia
    Lipp, Rainer
    Partelli, Stefano
    Falconi, Massimo
    Wiedenmann, Bertram
    Delle Fave, Gianfranco
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (05): : 1486 - 1494
  • [27] Challenging in Predicting Response in Treatment of Neuroendocrine Pancreatic Tumors: Nutritional Factors
    Tejera, C.
    Flores, J. A.
    Barzola Navarro, E. J.
    Rubio, A.
    Galeano, F.
    Blanco, G.
    Lopez, O.
    Luengo, L. M.
    Botello Martinez, F.
    Fernandez, J. M.
    Lopez, D.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 239 - 239
  • [28] Factors Predicting Prognosis in Metastatic Grade 1 Gastro-entero-pancreatic Neuroendocrine Tumors
    Pandrowala, Saneya A.
    Kapoor, Deeksha
    Kunte, Aditya
    Chopde, Amit
    Puranik, Ameya
    Dev, Indraja Devidas
    Parghane, Rahul
    Basu, Sandip
    Ramaswamy, Anant
    Ostwal, Vikas
    Chaudhari, Vikram A.
    Bhandare, Manish S.
    Shrikhande, Shailesh V.
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (03) : 1220 - 1228
  • [29] Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution
    Sylvia L. Asa
    Sofia Asioli
    Suheyla Bozkurt
    Olivera Casar-Borota
    Laura Chinezu
    Nil Comunoglu
    Giulia Cossu
    Michael Cusimano
    Etienne Delgrange
    Peter Earls
    Shereen Ezzat
    Nurperi Gazioglu
    Ashley Grossman
    Federica Guaraldi
    Richard A. Hickman
    Hidetoshi Ikeda
    Marie-Lise Jaffrain-Rea
    Niki Karavitaki
    Ivana Kraljević
    Stefano La Rosa
    Emilija Manojlović-Gačić
    Niki Maartens
    Ian E. McCutcheon
    Mahmoud Messerer
    Ozgur Mete
    Hiroshi Nishioka
    Buge Oz
    Sara Pakbaz
    Melike Pekmezci
    Arie Perry
    Lilla Reiniger
    Federico Roncaroli
    Wolfgang Saeger
    Figen Söylemezoğlu
    Osamu Tachibana
    Jacqueline Trouillas
    John Turchini
    Silvia Uccella
    Chiara Villa
    Shozo Yamada
    Sema Yarman
    Pituitary, 2020, 23 : 322 - 325
  • [30] Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution
    Asa, Sylvia L.
    Asioli, Sofia
    Bozkurt, Suheyla
    Casar-Borota, Olivera
    Chinezu, Laura
    Comunoglu, Nil
    Cossu, Giulia
    Cusimano, Michael
    Delgrange, Etienne
    Earls, Peter
    Ezzat, Shereen
    Gazioglu, Nurperi
    Grossman, Ashley
    Guaraldi, Federica
    Hickman, Richard A.
    Ikeda, Hidetoshi
    Jaffrain-Rea, Marie-Lise
    Karavitaki, Niki
    Kraljevic, Ivana
    La Rosa, Stefano
    Manojlovic-Gacic, Emilija
    Maartens, Niki
    McCutcheon, Ian E.
    Messerer, Mahmoud
    Mete, Ozgur
    Nishioka, Hiroshi
    Oz, Buge
    Pakbaz, Sara
    Pekmezci, Melike
    Perry, Arie
    Reiniger, Lilla
    Roncaroli, Federico
    Saeger, Wolfgang
    Soylemezoglu, Figen
    Tachibana, Osamu
    Trouillas, Jacqueline
    Turchini, John
    Uccella, Silvia
    Villa, Chiara
    Yamada, Shozo
    Yarman, Sema
    PITUITARY, 2020, 23 (03) : 322 - 325
12345